2023 FDA Health Services Administration Telemedicine 
Health Law Advisor
MARCH 7, 2023
The proposed rules are more restrictive than the DEA emergency waivers under which providers conducted telemedicine prescribing for the last three years, but are less restrictive in comparison to the pre-PHE regulations applicable to telemedicine prescribing of controlled substances under the federal Controlled Substances Act (“CSA”).
Healthcare Law Today
NOVEMBER 9, 2022
Starting January 1, 2023, Medicare will cover telehealth-based treatment services delivered by federally-accredited opioid treatment programs (OTPs), commonly referred to as “methadone clinics.” This flexibility will be in place until the end of CY 2023. Want to Learn More?
Bill of Health
NOVEMBER 15, 2023
DEA has done little to reduce the appearance of agency capture by the Opioid Treatment Program (OTP) industry, while FDA was years behind the evidence in approving over-the-counter naloxone. Code § 1701 et seq.
Expert insights. Personalized for you.
52 
Let's personalize your content